Press-release for stocks related to pharma for SNYNF

tags : Pharma symbols : SNYNF

save search

Innate Pharma Presents at AACR 2024 Preclinical Efficacy of Its Pre-IND Drug Candidate IPH45, a Novel Nectin-4 Antibody Drug Conjugate
Published: 2024-04-10 (Crawled : 09:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -1.65% | O: -0.01% H: 0.0% C: 0.0%
SNY | News | $45.39 -1.56% -1.58% 4.3M

Health Technology

| -4.25% | O: -0.32% H: 0.0% C: 0.0%
IPHA | $2.35 -2.49% -0.42% 11K

Health Technology

| -9.62% | O: -3.85% H: 1.2% C: 0.8%
iph45 pharma drug candidate antibody preclinical

Innate Pharma Announces Its Participation in Upcoming April 2024 Investor Conference
Published: 2024-04-09 (Crawled : 09:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -1.38% | O: 0.28% H: 0.0% C: 0.0%
SNY | News | $45.39 -1.56% -1.58% 4.3M

Health Technology

| -3.83% | O: -0.38% H: 0.95% C: 0.83%
IPHA | $2.35 -2.49% -0.42% 11K

Health Technology

| -5.62% | O: 2.57% H: 1.81% C: 1.81%
pharma conference

Innate Pharma Files Its 2023 Universal Registration Document (Document d’enregistrement Universel) and 2023 Annual Report on Form 20-F
Published: 2024-04-05 (Crawled : 11:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -3.54% | O: -1.77% H: 0.0% C: -1.81%
SNY | News | $45.39 -1.56% -1.58% 4.3M

Health Technology

| -6.35% | O: -3.44% H: 0.0% C: 0.0%
IPHA | $2.35 -2.49% -0.42% 11K

Health Technology

| -6.0% | O: -0.4% H: 0.0% C: -5.22%
pharma report universal

Notice of Annual General Meeting of Vicore Pharma Holding AB (publ)
Published: 2024-04-04 (Crawled : 09:00) - biospace.com/
SNY | News | $45.39 -1.56% -1.58% 4.3M

Health Technology

| -5.25% | O: 1.18% H: 0.0% C: 0.0%
pharma meeting

Innate Pharma Reports Full Year 2023 Financial Results and Business Update
Published: 2024-03-21 (Crawled : 09:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -2.29% | O: 0.14% H: 0.24% C: 0.24%
SNY | News | $45.39 -1.56% -1.58% 4.3M

Health Technology

| -3.83% | O: 0.3% H: 0.0% C: 0.0%
IPHA | $2.35 -2.49% -0.42% 11K

Health Technology

| -6.0% | O: -4.51% H: 4.25% C: 0.96%
pharma business year update financial results

Innate Pharma Announces Its Participation to Upcoming Investor Conference - March 19, 2024
Published: 2024-03-19 (Crawled : 08:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -2.31% | O: -0.02% H: 0.0% C: 0.0%
SNY | News | $45.39 -1.56% -1.58% 4.3M

Health Technology

| -5.25% | O: -1.51% H: 0.0% C: 0.0%
IPHA | $2.35 -2.49% -0.42% 11K

Health Technology

| -1.67% | O: 0.84% H: 4.56% C: 0.83%
pharma conference

Innate Pharma Announces Conference Call and Webcast for Full Year 2023 Financial Results
Published: 2024-03-14 (Crawled : 09:00) - biospace.com/
SNY | News | $45.39 -1.56% -1.58% 4.3M

Health Technology

| -5.82% | O: 0.23% H: 0.0% C: 0.0%
IPHA | $2.35 -2.49% -0.42% 11K

Health Technology

| -6.0% | O: -2.4% H: 3.69% C: 3.28%
pharma conference year financial results

Vaccine research market size to grow at a CAGR of 9.88% from 2022 to 2027, Abbott Laboratories, Astellas Pharma Inc., AstraZeneca Plc, more to emerge as key players, Technavio
Published: 2024-03-11 (Crawled : 14:30) - prnewswire.com
CMXHF | $172.54 -1.41% -19.21% 140

n/a

| -5.41% | O: 0.41% H: 0.0% C: 0.0%
CSLLY | $86.918 -1.19% 3.3% 60K

n/a

| -6.8% | O: -4.92% H: 3.76% C: 3.44%
GLAXF | $20.2 0.65% -14.18% 40

Health Technology

| -5.92% | O: -3.4% H: 1.49% C: 1.49%
AZNCF | $138.24 -1.36% -4.19% 800

Health Technology

| 3.19% | O: 1.55% H: 0.82% C: 0.16%
ALPMY | $9.47 0.11% -1.11% 520K

Manufacturing

| -12.05% | O: -1.41% H: 5.06% C: 4.01%
GSK | $39.27 -0.83% 0.26% 1.9M

Health Technology

| -8.21% | O: -0.6% H: 0.19% C: 0.09%
ABT | News | $105.27 -0.6% -0.38% 5.9M

Health Technology

| -11.91% | O: 0.26% H: 0.0% C: 0.0%
SNY | News | $45.39 -1.56% -1.58% 4.3M

Health Technology

| -5.31% | O: 0.57% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 3.6M

Health Technology

| 2.65% | O: 1.08% H: 0.82% C: 0.67%
pharma vaccine astrazeneca research key market

Innate Pharma to Present Nectin-4 Antibody Drug Conjugate IPH45 Preclinical Data at AACR 2024
Published: 2024-03-06 (Crawled : 11:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -1.01% | O: 0.0% H: 0.8% C: 0.8%
SNY | News | $45.39 -1.56% -1.58% 4.3M

Health Technology

| -4.29% | O: -0.45% H: 0.0% C: 0.0%
IPHA | $2.35 -2.49% -0.42% 11K

Health Technology

| -8.56% | O: 0.78% H: 1.93% C: 0.97%
iph45 pharma drug antibody preclinical

Zealand Pharma Announces Financial Results for the Full Year 2023
Published: 2024-02-27 (Crawled : 06:00) - globenewswire.com
SNY | News | $45.39 -1.56% -1.58% 4.3M

Health Technology

| -6.76% | O: -0.94% H: 0.0% C: 0.0%
pharma year financial results

Innate Pharma Announces Its Participation to Upcoming March 2024 Investor Conference
Published: 2024-02-21 (Crawled : 07:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -1.49% | O: 1.7% H: 0.0% C: 0.0%
SNY | News | $45.39 -1.56% -1.58% 4.3M

Health Technology

| -3.99% | O: -0.57% H: 0.0% C: 0.0%
IPHA | $2.35 -2.49% -0.42% 11K

Health Technology

| -9.27% | O: -2.32% H: 0.0% C: 0.0%
pharma conference

Number of Shares and Voting Rights of Innate Pharma as of January 1, 2024
Published: 2024-01-12 (Crawled : 11:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -11.92% | O: 0.71% H: 0.0% C: 0.0%
SNY | News | $45.39 -1.56% -1.58% 4.3M

Health Technology

| -13.05% | O: 0.06% H: 0.0% C: 0.0%
IPHA | $2.35 -2.49% -0.42% 11K

Health Technology

| -15.77% | O: 0.0% H: 0.36% C: 0.36%
pharma

Medison Pharma Announces Agreement with Regeneron Pharmaceuticals to Commercialize Libtayo® (cemiplimab) in Multiple Countries
Published: 2024-01-08 (Crawled : 12:30) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -8.67% | O: 2.07% H: 0.48% C: 0.48%
SNY | News | $45.39 -1.56% -1.58% 4.3M

Health Technology

| -10.66% | O: 1.16% H: 0.0% C: 0.0%
REGN | $893.99 -0.8% -0.84% 450K

Health Technology

| -1.31% | O: -2.54% H: 1.53% C: 1.45%
libtayo pharma pharmaceuticals agreement

Innate Pharma Strengthens Leadership and Appoints Two New Members to Its Executive Board
Published: 2024-01-04 (Crawled : 09:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -7.51% | O: 1.62% H: 0.0% C: 0.0%
SNY | News | $45.39 -1.56% -1.58% 4.3M

Health Technology

| -9.09% | O: 1.12% H: 0.93% C: 0.77%
IPHA | $2.35 -2.49% -0.42% 11K

Health Technology

| -15.47% | O: 6.47% H: 3.65% C: -2.36%
pharma

Innate Pharma Announces U.S. FDA Lifts Partial Clinical Hold on Lacutamab Clinical Program
Published: 2024-01-04 (Crawled : 08:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -7.51% | O: 1.62% H: 0.0% C: 0.0%
SNY | News | $45.39 -1.56% -1.58% 4.3M

Health Technology

| -9.09% | O: 1.12% H: 0.93% C: 0.77%
IPHA | $2.35 -2.49% -0.42% 11K

Health Technology

| -15.47% | O: 6.47% H: 3.65% C: -2.36%
fda pharma program

Innate Pharma Announces Licensing of a Fourth Natural Killer Cell Engager in Oncology to Sanofi
Published: 2023-12-19 (Crawled : 08:00) - biospace.com/
NVO | $122.75 -1.43% 0.65% 2.7M

Health Technology

| 25.81% | O: 0.91% H: 0.72% C: 0.11%
SNY | News | $45.39 -1.56% -1.58% 4.3M

Health Technology

| -6.07% | O: 0.45% H: 0.0% C: 0.0%
IPHA | $2.35 -2.49% -0.42% 11K

Health Technology

| -4.08% | O: 13.88% H: 0.0% C: -3.58%
pharma natural cell sanofi

Innate Pharma Announces Leadership Change - December 18, 2023
Published: 2023-12-18 (Crawled : 10:00) - biospace.com/
SNY | News | $45.39 -1.56% -1.58% 4.3M

Health Technology

| -4.89% | O: 1.25% H: 0.0% C: 0.0%
IPHA | $2.35 -2.49% -0.42% 11K

Health Technology

| -2.49% | O: 2.9% H: 2.02% C: -1.21%
pharma change

Biden, Big Pharma Increasingly at Loggerheads in Run-Up to 2024 Election
Published: 2023-12-15 (Crawled : 22:00) - biospace.com/
SNY | News | $45.39 -1.56% -1.58% 4.3M

Health Technology

| -5.78% | O: -0.93% H: 0.0% C: 0.0%
pharma